Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders

Abstract

Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders.

Keywords

• Follicular lymphoma
• mantle cell lymphoma
• Chronic lymphocytic leukemia
• molecular remission
• PCR